(Q33802781)

English

Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Mario Regazzi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Renato Maserati

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paola Villani

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maria Cusato

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Patrizia Zucchi

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Elena Briganti

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rinaldo Roda

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Luca Sacchelli

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Francesca Gatti

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Palma Delle Foglie

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Giulia Nardini

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paolo Fabris

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Fernanda Mori

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paula Castelli

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lucia Testa

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

643-649

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

High concentrations of nelfinavir as an independent risk factor for lipodystrophy in human immunodeficiency virus-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Hepatitis C and human immunodeficiency virus coinfections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

4 July 2018

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547212

30 October 2018

The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cirrhosis: diagnosis with sonographic study of the liver surface

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs in liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.2.643-649.2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33802781&oldid=1543908056"